Cytotoxicity against tumour cells is mostly mediated by natural killer (NK) or lymphokine-activated killer (LAK) cells and tumour-infiltrating lymphocytes (TILs). In the case of LAK cells the cytotoxicity is non-major histocompatibility complex (MHC) restricted. In contrast, the cytotoxicity exerted by lymphocytes derived from TILs may be MHC restricted, and such cells possess T-cell characteristics (for a review see Baxevanis & Papamichail, 1994) . Adoptive immunotherapy in humans with either autologous LAK cells or TILs expanded in vitro with IL-2 is mostly unsuccessful since some 60% of patients with metastatic disease fail to respond to this therapy (Rosenberg et al., 1988; Parkinson et al., 1990) .
Because of the toxicities associated with LAK/IL-2 therapy and technical difficulties in generating TILs from certain solid tumour specimens, several laboratories initiated studies on lymphocytes infiltrating malignant effusions. Blanchard et al. (1988) isolated malignant effusion-associated mononuclear cells (MEMNCs), which upon activation with IL-2 exhibited non-MHC-restricted lytic activity. Preferential cytotoxicity for autologous tumour cells by CD3' MEMNCs has been demonstrated in bulk cultures (Heo et al., 1988) and at the clonal level (Fermni et al., 1985; loannides et al., 1991a) . Such cells have been demonstrated to recognise multiple antigenic epitopes on autologous tumour cells (loannides et al., 1991b) .
Interleukin 1 (IL-1) plays a central role in immune responses by acting on different cell types and exhibiting multiple biological activities. Thus, IL-1 has been shown to modulate the proliferation, maturation and biological activity of B lymphocytes (Falkoff et al., 1984) , T lymphocytes (Mizel, 1982) and monocytes (Baxevanis et al., 1993a ; Uhl et al., 1989) . IL-1 was also found to increase the expression of specific genes (e.g. IL-2 receptor a-gene; Freimuth et al., 1989) and to stimulate the synthesis of other cytokines [e.g. IL-2, tumour necrosis factor (TNF) and IL-6; Schmidt & Tocci, 1990] including itself (Dinarello et al., 1987) . Recent published data demonstrate that IL-1 is one of the main co-stimulators for both naive and memory T-cell activation (Plebanski et al., 1992) generation of effector (e.g. cytotoxic) T-cell types. In support of this. IL-1 has been shown to inhibit tumour growth in experimental animals (Forni et al.. 1989) and to potentiate T cell-denrved tumour-specific responses (Cozzolino et al., 1987) . We report here that IL-l synergises with IL-2 for the expansion of CD8 + cytotoxic T lymphocytes (CTLs) in MEMNC cultures from malignant effusions (pleural and ascites) from patients with advanced lung, breast and ovarian cancer. This expansion was associated with increased production of IFN-y in the cultures and resulted in increased levels of cytotoxicity against autologous tumour cells. Thus selective outgrowth of IL-2-activated CD8+ malignant effusion- Table I . The age of the patients ranged from 30 to 79 years and patients had received no treatment with anti-cancer agents within 1 month of sample collection.
Monoclonal antibodies
Fluorescein isothiocyanate (FHTC)-conjugated series of monoclonal antibodies (MAbs) (anti-CD3, -CD14, -CD20, -CD16, -CD25 and anti-HLA-DR), and phycoerythnn (PE)-conjugated anti-CD4, -CD8, -CD25 and anti-HLA-DR MAbs were purchased from Becton Dickinson (Mountain View, CA, USA). Cells were incubated with the relevant MAb at 4°C for 30 min, and the antigen expression was analysed using a FACScan (Becton Dickinson) (Baxevanis et at., 1992) .
Tissue culture media and reagents RPMI-1640 medium, fetal calf serum (FCS) and Hanks' balanced salt solution (HBSS) were purchased from Gibco Br. J. Cancer (1994) . 70, 625-630 (D Macmillan Press Ltd.. 1994 Preparation and culture of effusion cells Specimens of pleural or peritoneal effusions (500-2,000 ml) were obtained from the patients and centrifuged at 400 g for 10 min at 25'C to sediment cells. Cells were washed with sterile HBSS and then layered on Ficoll-Hypaque cushions. After centrifugation at 400 g for 20 min, tumour cells and mononuclear cells were collected from the interface and washed twice in HBSS. Tumour cells were separated from mononuclear cells by centrifugation on discontinuous Percoll density gradients as previously reported (Papamichail & Baxevanis, 1992) . In brief, cell suspensions were centrifuged on differential Percoll gradients, and the tumour ceUs were collected from the upper interface. The MEMNCs were collected from the lower interface. Cells were washed with HBSS and checked for viability with the aid of trypan blue dye. Viability was always >90%. Tumour ceUls were used either fresh or cryopreserved in liquid nitrogen in 90% FCS plus 10% dimethylsulphoxide until ready for use in cultures or as target cells in the cytotoxicity assays (see below), at which time cells were carefully thawed, slowly diluted in RPMI-1640, and washed. Tumours were accepted for assay if viability was >80%. MEMNCs were diluted in complete medium at a concentration of 2.5-5.0 x I0W cells ml-' in the presence of 2.5-5.0 x 104 autologous tumour cells ml-' and distributed in 2 ml aliquots in 24-well plates (Costar, Cambridge, MA, USA) at 37C, in 5% carbon dioxide and 95% humidity. After 3 days, IL-2 (100 U ml-'), alone or in combination with IL-1p (l, , was added in cultures.
Two days later half of the volume of each well (1 ml) was replenished with fresh complete medium containing the cytokines and 2.5-5.0 x 104 autologous tumour cells. During the first 2 weeks cells grew slowly; thereafter an accelerated growth was observed. MEMNC cultures were passaged weekly with 1 ml of fresh complete medium supplemented with fresh cytokines. After 3-5 passages cultures were supplemented once more with autologous tumour cells. Cells were kept throughout the entire culture period in 24-well plates, whereby the cell density at every passage was returned (using fresh complete medium and cytokines) to 2.5-5.0 x I05 cells ml 1.
Cvtotoxicity assai-
This was performed as reported previously (Baxevanis et al., 1993b (Hannet et al.. 1992) . A significant proportion of both CD3+ CD4+ and CD3+ CD8+ subsets was found to bear the IL-2 receptor (33% and 39% of CD4' and CD8+ subsets respectively). a marker of activated T cells. While the number of CD20+ B cells and CD16+ natural killer (NK) cells was low, with an average of 3 ± 2% and 6 ± 5% respectively. normal proportions of CD14+ monocytes (14 ± 6%) were found (Table II) .
MEMNCs were cultured in the presence of IL-2 (100 U ml-') alone or supplemented with IL-1l (1.000 U ml'). MEMNCs from all 20 patients increased in number when cultured with IL-2 and reached maximum propagation at an average of 39 ± 13 days with a mean n-fold increase of 224 ± 122 ranging from 90 to 550 (Table  III (Figures I and 2) .
MEMNC cultures which exhibited preferential killing of autologous tumour targets (Figure 1 ; MEMNCs from patients 2, 6, 10, 11 and 16) consisted mainly (>68%) of activated CD3+CD8+ T cells (Figure 2) , whereas all other cultures [i.e. those consisting of either CD3+ CD4+ T cells in high numbers or mixtures of both T-cefl subsets (Figure 2) ] exhibited potent cytotoxicity against autologous and allogeneic tumour cells (Figure 1) .
A preferential outgrowth of CD3+ CD8+ cells was induced in the same MEMNC cultures when these were initiated with IL-2 (100Uml-') plus IL-lp (1,00OUml-') (mean value from 20 cultures 68 ± 15% compared with 45 ± 24% in cultures with IL-2 alone; P <0.02) (Figure 2) . Preliminary experiments revealed that doses of IL-1p lower than 1,000 U ml' remained without any statistically significant effect (data not shown). The 17  32  10  10  3  6  2  72  40  10  30  13  7  3  12  3  52  29  9  20  5  25  5  20   4  83  60  13  25  12  10  2  3  5  66  32  15  35  17  14  10  15  6  71  36  12  39  13  20  1  1  7  68  38  17  29  10  17  6  9  8  81  40  6  42  20  10  2  5  9  77  37  16  26  12  15  6  9   10  82  50  20  32  15  3  2  9  11  86  35  9  49  22  6  1  2  12  75  35  13  41   15  13  6  7  13  72  36  15  36  10  20  5  3  14  83  49  22  40  17  5  1  2  15  66  42  7  26  6  22  1  3  16  75  50  9  29  9  20  5  2  17  58  28  12  30  12  26  6  5  18  70  39  15  30  10  12  3  9  19  82  32  13  50  25  12  2  2  20  92  30  16  32  13 Figure 3 . there was a significant increase in IFN-y levels in MEMNCs cultured with IL-2 and IL-lp (mean value from 20 cultures: 340 ± 101 pg ml-') compared with 214± 108 pgml-' (P<0.01) produced in the same cultures incubated with IL-2 alone. By' comparing the levels of endogeneously produced IFN-y in MEMNC with IL-2 alone. it becomes clear that these levels were increased in cultures which displayed autologous tumour-specific cytotoxicity (compare Figure 3 with Figure 1 ). thus confirming their role in promoting CTL activity agaist autologous tumour cells. (Baxevanis & Papamichail. 1994) . Thus it remains uncertain if autologous tumour-specific T cells exist in certain tumours and not in others. Based upon the in vitro demonstration of autotumour-specific CTLs in the ascitic fluid but not in the tumour specimens of patients with the same type of tumour (Heo et al.. 1988 (Heo et al.. : loannides et al.. 1991a . there are indications that it may be possible to generate autologous tumour-specific cytotoxicity under appropriate culture conditions. Therefore, much effort is now being aimed at elucidating the regulatory function of numerous cytokines associated with and potentially involved in the induction of CTLs with specificity for autologous tumour cells among TILs or MEMNCs. The elucidation of regulation of anti-tumour cytolytic responses is important not only for understanding the interaction of the immune system with tumour cells but also for the potential development of effective methods in cancer immunotherapy. Previous studies from our laboratory have shown that exogenous IFN-'y acts synergistically with IL-2 to promote autologous tumourreactive CTLs among TILs or MEMNCs (Papamichail & Baxevanis. 1992) and to augment anti-tumour cytolytic responses in patients with cancer (Baxevanis et al.. 1993c (Vaccarello et al., 1990; loannides et al., 1991c) . The addition of IFN-y or TNF-a to TILs cultured in the presence of TNF-x and IL-2 significantly augmented cytotoxicity against autologous tumour (Shimizu et al., 1991) . In the present study we report a synergistic effect of IL-lB with IL-2 for the preferential outgrowth of CD8+ CTLs from lymphocytes infiltrating malignant effusions from patients with metastatic cancer. This expansion resulted in increased levels of cytotoxicity against autologous tumour cells and was associated with increased production of IFN-y in the MEMNC cultures. IL-lp alone was not capable of inducing expansion or cytotoxicity in MEMNCs (data not shown). To our knowledge our data provide novel evidence for the involvement of IL-1p in the selective increase of autologous tumour-reactive CD8+ CTLs among MEMNCs. since so far synergy of IL-1 and IL-2 has been demonstrated only in the generation of LAK activity (Crump et al.. 1989) . whereby IL-2 up-regulated the expression of IL-2 receptor on penrpheral blood mononuclear cells (PBMCs). Indirect eVidence for the involvement of IL-1 in the generation of autologous tumour CTLs was provided in a previous report (Osband et al.. 1990) . in which high levels of IL-1 in autologous lymphokine mixtures (ALMs) were shown to associate with successful cellular adoptive immunotherapy in patients with renal cell carcinoma using PBMCs activated in vitro with ALMs (Osband et al.. 1990 ).
Although not yet precisely analysed. IL-lp seems to mediate its effect indirectly by stimulating increased production of IFN-y. IFN-y is known to be involved in CTL generation (Chen et al.. 1986 : Gromo et al.. 1987 ) and activation of CD8+ cells (Siegel. 1988) . Moreover, increased production of IFN-y could be measured in IL-2 + TNF-a-stimulated TIL cultures, which exhibited preferential cytotoxicity for autologous tumour cells (Wang et al.. 1989 
